The differential intensity of lysis induced by trastuzumab alone was not due to a heterogenous HER2 expression as shown by similar staining patterns of the tumor cells with trastzumab (Figure 1B; Figure S1B in Supplementary Material). This evidence concerns the gene ERBB2 and neoplasm.